Oxcarbazepine
(Redirected from Trileptal)
| Drug monograph · NCLEX study reference | |
| Trade names | Trileptal |
|---|---|
| Therapeutic class | Anticonvulsant |
| Pharmacologic class | Sodium channel blocker (carbamazepine analog) |
| Onset / peak / duration | Effect over days. |
| Half-life / level | Active metabolite half-life about 9 hours; level not routine. |
| Routes | PO (oral) |
| High-alert (ISMP) | No |
| Black box warning | None |
| Antidote / reversal | None. |
| Pregnancy / lactation | Use only if essential. |
Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.
Oxcarbazepine (brand name Trileptal) — Anticonvulsant; Sodium channel blocker (carbamazepine analog).
Identification
- Therapeutic class: Anticonvulsant.
- Pharmacologic class: Sodium channel blocker (carbamazepine analog).
Pharmacology
- Mechanism of action: Blocks sodium channels with fewer autoinduction effects than carbamazepine.
- Onset / peak / duration: Effect over days.
- Half-life / therapeutic level: Active metabolite half-life about 9 hours; level not routine.
Clinical use
- Indications: Focal seizures.
- Usual dose, route, frequency: Titrated PO twice daily; liquid available.
- Maximum dose / adjustments: Reduce in renal impairment.
Safety
- Contraindications: Hypersensitivity to oxcarbazepine.
- Black box warning: None.
- Interactions: Oral contraceptives (reduced), other antiepileptics.
- Pregnancy / lactation: Use only if essential.
- High-alert: No.
Adverse effects
- Common side effects: Dizziness, somnolence, nausea, diplopia.
- Serious effects to report: Hyponatremia, serious rash, HLA-B*1502-associated reactions.
- Antidote / reversal: None.
Nursing process
- Assessment before administration: Sodium, seizure baseline.
- Interventions during therapy: Monitor sodium, especially in elderly.
- Monitor: Sodium, seizure frequency.
- Evaluation / expected outcome: Seizure control.
Patient teaching
- Patient teaching: Report rash; backup contraception.
- Notify provider if: Rash, confusion, severe headache.
- Administration tips: With or without food.